The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Infliximab

Australian Public Assessment Report

AusPAR

AusPAR: infliximab [PDF, 1.01 MB]

AusPAR: infliximab [Word, 1.47 MB]

Attachment: Product Information: infliximab [PDF, 586.97 KB]

Attachment: Product Information: infliximab [Word, 344.75 KB]

Attachment: Extract from Clinical Evaluation Report: infliximab [PDF, 1.48 MB]

Attachment: Extract from Clinical Evaluation Report: infliximab [Word, 3.95 MB]

Device/Product Name

Renflexis

Active ingredients

Infliximab

AusPAR Date

12 October 2017

Published

14 November 2017

Submission Number

2015-02764-1-3

Submission Type

New biosimilar medicine

Decision

Approved